2022 "Science and Technology Innovation China" Chinese Medicine Industry Science and Technology Service Group Project Launch Meeting and Corporate Inspection Club is held in Beijing

On June 23, 2022, the 2022 "Science and Technology Innovation China" Chinese Medicine Industry Science and Technology Service Troupe project and corporate needs online consultation meeting hosted by the Chinese Academy of Traditional Chinese Medicine and supported by the Jinan Science and Technology Association was held in Beijing. The theme of this meeting is "solving problems, promoting transformation, and helping entrepreneurship". Industry experts and corporate representatives participated in live broadcast activities through the form of online and offline combination.

Liu Xiaofang, deputy director of the Innovation Service Center of the China Science and Technology Association, Liu Ping, deputy secretary -general of the Chinese Academy of Traditional Chinese Medicine, Li Wu, deputy chairman of the Jinan Science and Technology Association, and other leaders, Professor Cao Junling, Executive Dean of Luoyang Hospital of Beijing University of Traditional Chinese Medicine, Professor Cao Junling Researcher Ma Ming at the Department of Natural Pharmacy at Peking University, Professor Li Geng, deputy director of the Scientific Research Office of the Institute of Pharmaceutical and Pharmaceuticals of the Chinese Academy of Medical Sciences, researcher Zhang Weiku, China and Japan Friendship Hospital, and researcher Lin Sheng from Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine attended the meeting. The meeting was chaired by Zhang Xiaoxiao, director of the Development and Research Office of the Chinese Medicine Society.

In his speech, Liu Ping stated that he learned to unite and lead Guangda Traditional Chinese Medicine Science and Technology Workers into the new development pattern, build platforms, solve problems, promote transformation, and help entrepreneurship. The supply of sexual technology to create effective demand, organize an empowerment and open cooperation to drive the orderly sinking of innovative resources at home and abroad, create a good innovation and entrepreneurial ecosystem, and help industrial transformation and upgrading. Wang Xiao, director of the Society of Science and Technology Association of Jinan City, introduced the status and development prospects of the Chinese medicine industry in Jinan.

Guo Jihua, the Chinese Society of Chinese Medicine, said in the background and task introduction of the “Science and Technology Innovation China” Chinese Medicine Industry Science and Technology Service Troupe project that the Society has been commissioned by the Chinese Association for Science and Technology and has undertaken the “Science and Technology Innovation China” industrial science and technology service group project since 2021. During the implementation of 2021, the scientific research and innovation and academic development needs of 6 companies and 11 products were directly answered through the form of online consultation and expert seminars. At the same time Innovative needs, the Society has launched the "Joint Research Project of the Chinese Academy of Chinese Medicine", which mainly serves the clinical research, basic research and other aspects of scientific research needs of the company's products. At present, the launching meeting of 3 companies and 3 projects has been completed. In 2022, the service group will focus on the field of traditional Chinese medicine around the field of technological issues and the implementation of scientific and technological achievements.

In the online consultation session of enterprise needs, Shandong Chenghui Shuangda Group Corporation, Zhang Peng, Shandong Wahua Pharmaceutical Technology Co., Ltd. Zeng Yingzi, Shandong Lunan Pharmaceutical Group Cheng Guoliang, Ruiyang Pharmaceutical Co., Ltd. Wang Lianqi, Shandong Yili Lailai Nearly 10 companies including Biotechnology Co., Ltd. Tian Baolan and Shandong Fangming Pharmaceutical Group Co., Ltd. Wang Feilong have proposed problems, problems and needs in technological research and development and promotion, covering comprehensive evaluation of Chinese medicines, clinical research on Chinese patent medicines, clinical research on Chinese medicine, and Chinese medicines. The secondary development of large varieties and the quality control standards of Chinese medicine particles improved/dosage optimization, etc., the participating experts conducted a "one -to -one" exchange discussion with the company's representatives around specific issues. The atmosphere of online exchanges is strong, and enterprise representatives have expressed their benefits. Zeng Yingzi, a representative of the enterprise, said that the meeting was very pragmatic, and the company had a lot of gains. It was possible to solve the needs and problems of corporate needs in such a short time at the meeting.

Professor Ma Ming, Department of Natural Pharmacy of Peking University School of Pharmacy, answers Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd.

Deputy Director Liu Xiaofang of the Innovation Service Center of the China Science and Technology Association Society said in a concluding speech that in 2021, the Science and Technology Service Troupe of the Chinese Traditional Chinese Medicine Society was rated as an excellent service group. The technical difficulties and needs of the enterprise have been solved in a timely manner, and a demonstration and example for the "Science and Technology Innovation China" science and technology service group. I hope that in the work of the science and technology service group in 2022, learn to continue to actively explore the innovation model, and vigorously serve the key industries such as Jinan region and other key industries develop.

- END -